�������ý

Speaker: Chancellor Donald, MD

• What approaches have been recently implemented to enhance the treatment of acute pain crisis in patients with sickle cell disease?
• What medications have been shown to decrease the rate of complications in patients with sickle cell disease?
• How has gene editing allowed sickle cell disease to be cured?

Speaker: Tamar H. Taddei, MD, FACP

• What are the common causes of abnormal liver enzymes observed in hospitalized patients?
• When should you consider observation and when should you initiate diagnostic work-up for abnormal liver enzymes?
• When is referral to a gastroenterologist or hepatologist indicated?

Speaker: Noble Maleque, MD, FACP

• What is the prevalence and etiology of asymptomatic, symptomatic, and secondary hypertension in the inpatient setting?
• How do you manage the patient with asymptomatic and symptomatic hypertension, the timing of treatment, and monitoring after hospital discharge?
• What are the postdischarge adverse events associated with the treatment of asymptomatic inpatient hypertension?

Speaker: Gregory C. Kane, MD, MACP

• How does one choose among the various options available to treat hypoxemia?
• How does one prescribe and troubleshoot the noninvasive oxygenation treatment options?
• How does one initiate mechanical ventilation and what ventilator strategies can be used to improve oxygenation?

Speaker: Aditya S. Bharadwaj, MD, MBBS, FACC, FSCAI

• What are the latest management guidelines for type 1 and type 2 myocardial infarctions (MIs)?
• What is the recommended duration of antiplatelet and other therapies administered after MI?
• What are the core quality measures in MI care that physicians should be aware of?

Speaker: Shoshana J. Herzig, MD, MPH, FACP, SFHM

• What are the best opioid and nonopioid treatment options for patients with acute or chronic pain in the inpatient setting?
• How should you manage acute pain in patients with substance use disorder and those receiving medication-assisted treatment?
• What management and preventive strategies will help reduce treatment-related adverse events in these patients?

Speaker: Simona Jakab, MD, Member

• What is a high-value care approach to diagnosing the cause of new-onset acute liver failure and acute exacerbation of chronic liver disease?
• How do you best manage these two conditions in the hospital and avoid readmissions?
• When should you refer these patients for urgent or semiurgent liver transplant?

Speaker: Robert Cole Pueringer, MD, Member

• How do you compare and contrast the use of different approaches for the treatment of alcohol withdrawal in the detoxification unit and inpatient settings?
• What are the recent changes in the management of alcohol withdrawal syndrome?
• What outpatient treatment options should be considered at the time of discharge and other points-of-care transitions?

Speaker: John M. Kelso, MD

• How does food allergy present, and what is the high-value approach to evaluating a patient for a food allergy?
• When and how should a patient with a documented drug allergy be reexposed to that medication?
• What is the most high-value approach for diagnosing patients with an environment allergy?

Moderator: Eliseo Guallar, MD, DrPH, Member
Panelists: Stephanie Chang, MD, Member • Christina C. Wee, MD, MPH, FACP

• Become aware of recent studies with implications for internal medicine practice, research, and education.

Speaker: Jennifer A. Hanrahan, DO, MSc, Member

• What are the high-value approaches to selecting and prescribing antibiotics in the hospital setting?
• What are the common adverse events and drug–drug interactions associated with antibiotic use in the hospital?
• How can physicians become strong stewards and teachers of antibiotic use in the inpatient setting?

Speaker: Prashant Pendyala, MD

• What are the common electrolyte abnormalities observed in medical inpatients?
• What is the threshold to initiate work-up and treatment of such abnormalities?
• How do electrolyte disturbances aid in diagnosis and treatment?

Speaker: Anoop Agrawal, MD, FACP, FAAP

• What are the helpful and easy-to-use apps for physicians in the inpatient setting to serve as a point-of-care learning tool?
• What apps may physicians recommend to their inpatients for better understanding and management of their disease in the hospital and following discharge?
• What are the limitations of health apps that physicians should be aware of?

Speaker: Lisa N. Boggio, MD, Member

• In which patients should autoimmune hemolytic anemias be considered, and what is the diagnostic workup?
• How are warm autoimmune hemolytic anemia and cold agglutinin disease managed?
• When should you suspect drug-induced hemolytic anemia?

Speaker: Martine Sanon, MD

• What are the common noninfectious adverse events associated with a hospital stay?
• What are the risk factors for delirium, functional decline and pressure injuries for older patients who are hospitalized?
• What strategies can help prevent the incidence of these noninfectious adverse events in hospitalized patients?

Speaker: James T. Whitfill, MD, MBA, FACP, FSIIM

• How are physicians using artificial intelligence (AI) to complement medical decision making (e.g., diagnostic reasoning)?
• What are the current applications of AI in internal medicine?
• Why is physician AI vigilance important?

Speaker: Adrian BaudyIV, MD, MBA, Member

• At what GFR should a patient undergo additional evaluation for progressive kidney disease, and how should that patient be evaluated?
• What is the core of CKD management for an internal medicine physician, including issues related to hypertension, diabetes mellitus, coronary artery disease, and acidosis?
• When should a patient with CKD be referred to a nephrologist?

Director: Howard Weitz, MD, MACP, FRCP (Lond.), FACC
Co-Director: David L. Fischman, MD, FACP
Panelists: Rene J. AlvarezJr., MD, FACP, FACC, FAHA • Kelley Branch, MD, MSc, Member • Daniel Frisch, MD • John McPherson, MD, FACP, FACC • Geno J. Merli, MD, MACP, FHM, FSVM • Andrew C. Peters, MD, FACP, FACC, FASE • Amy West Pollak, MD, MSc, FAHA, FACC

Speaker: Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM

• How do you diagnose and treat infectious endocarditis?
• How do you treat initial and recurrent Clostridioides (formerly Clostridium) difficile and prevent subsequent infections?
• How do you manage patients who are critically ill and in the ICU using appropriate antimicrobial stewardship?

Moderator: John B. Bundrick, MD, MACP
Moderator: John B. Bundrick, MD, MACP
Moderator: John B. Bundrick, MD, MACP
Panelists: Michael W. Cullen, MD, FACC
Panelists: Michael W. Cullen, MD, FACC
Panelists: Michael W. Cullen, MD, FACC • Rodolfo Savica, MD, PhD • Rodolfo Savica, MD, PhD • Rodolfo Savica, MD, PhD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: John B. Bundrick, MD, MACP
Moderator: John B. Bundrick, MD, MACP
Moderator: John B. Bundrick, MD, MACP
Panelists: Andrea Kattah, MD
Panelists: Andrea Kattah, MD
Panelists: Andrea Kattah, MD • Jacob J. Strand, MD, FACP • Jacob J. Strand, MD, FACP • Jacob J. Strand, MD, FACP

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Speaker: John M. Kelso, MD

• How does a physician identify, manage, and treat life-threatening allergic and hypersensitivity conditions encountered in the inpatient setting?
• How does one navigate and address the drug and antibiotic allergies reported by patients and EHRs?
• When is it appropriate to apply inpatient direct oral penicillin challenge, and what is the best approach?

Speaker: Robert L. Trowbridge, MD, MACP

• What are the common diagnostic errors encountered in the inpatient setting?
• What are the predisposing factors and signals for diagnostic error in the inpatient setting?
• How can physicians mentor their trainees to avoid diagnostic errors?

Speaker: Matthew B. Carroll, MD, MACP, FACR

• What are rheumatologic urgencies that patients might be admitted for?
• What are the clinical, serologic, and radiographic findings to suggest a multisystem illness that could be due to a rheumatologic cause?
• How should disease-modifying agents (DMARDs) and biologics be managed during a patient's hospitalization?

Director: Robert A. Balk, MD, MCCM, MACP, FCCP
Panelists: Cherylee W.J. Chang, MD, FACP, FCCM, FNCS • David P. Gurka, MD, PhD, FACP • Steven M. Hollenberg, MD • Stanley A. NasrawayJr., MD, FCCM • Michael S. Niederman, MD, MACP, FCCP, FCCM • Stephen M. Pastores, MD, MACP, FCCP, FCCM

Speaker: Simrankaur Kaur Matta, MD

• What are the early, not-so-obvious clinical signs of rapid decompensation in patients hospitalized on the wards, and how do I identify them?
• What are the common clinical decision-supporting tools to diagnose such patients and manage them appropriately, especially when higher-level care transfer options are limited?
• What conditions can commonly present with early subclinical signs predictive of deterioration in the near future?

Moderator: Christine Laine, MD, MPH, FACP
Panelists: Liana K. Billings, MD • Zehavi Horowitz-Kugler, MD • Adam J. Obley, MD, FACP

• Authors of three selected articles to be published during the Internal Medicine Meeting will present a 10-minute overview of their article.

Speaker: Dana M. Blyth, MD, FACP, FIDSA

• What are the common health care–associated infections in the inpatient setting?
• What management tools can lead to early diagnoses and reduction in morbidity, mortality, and length of stay associated with such infections?
• What high-value care strategies can prevent the occurrence of such infections?

Speaker: Daniel D. Dressler, MD, MSc, FACP, MHM

• What are the essential elements of physical examination that should be performed during daily visit on medical inpatients?
• What are the high-yield physical exam findings that inpatient physicians should be familiar with?
• How do you develop mastery in the high yield physical signs and teach these concepts to trainees?

Speaker: Joseph E. Marine, MD, Member, FACC

• What are the appropriate indications for using telemetry in the hospital setting?
• What are the risks of overusing telemetry in the inpatient settings?
• When should cardiology be consulted for benign and asymptomatic findings on a routine telemetry monitoring?
• What major telemetry findings warrant further evaluation?

Moderator: Moises Auron, MD, FACP, FAAP, SFHM, FRCP
Moderator: Moises Auron, MD, FACP, FAAP, SFHM, FRCP
Panelists: Eileen Barrett, MD, MPH, MACP, FAMWA, SFHM
Panelists: Eileen Barrett, MD, MPH, MACP, FAMWA, SFHM • Richard M. WardropIII, MD, PhD, MACP, FAAP, SFHM • Richard M. WardropIII, MD, PhD, MACP, FAAP, SFHM

• Define value and the limitations of selected educational approaches in the setting of medical education.
• Apply principles of evidence-based curricular design and evaluation to one's own educational efforts.
• Introduce modifications to educational activities that are of low value.

Director: Jamie Newman, MD, MHA, MACP
Co-Director: Rachel Hammer, MD, MFA, Member
Panelists: Adrian BaudyIV, MD, MBA, Member • Abigail Byrne, MD, Member • Daniel C. DeSimone, MD • Steven Deitelzweig, MD, MMM, FACP, SFHM • A. Scott Keller, MD, MS, FACP • Fred Kusumoto, MD • Dragana Lovre, MD, Member • Sarah Miletello, MD

Moderator: Kari Esbensen, MD, PhD, FACP
Panelist: Kyle E. Karches, MD, PhD, FACP

• What are the emerging medical ethics and professionalism issues for internal medicine physicians today?
• How do ethical issues affect patient care?
• What should clinicians consider and how should interests be balanced when ethical challenges arise?

Moderator: Ross W. Hilliard, MD, FACP
Panelists: Sharath Kharidi, MD, FACP, FAMIA • Gary Weissman, MD

• Be exposed to current hot topics in medical informatics.
• Participants will interact with faculty to learn how these new technologies and concepts may affect their practices.
• Become familiar with ACP’s digital health resources.
• Hot Topic #1: Cybersecurity
• Hot Topic #2: Equity Considerations in Health Care AI

Moderator: Ellen Gelles, MD, FACP
Moderator: Ellen Gelles, MD, FACP
Panelists: Stephen P. Ma, MD
Panelists: Stephen P. Ma, MD • Deepti Pandita, MD, FACP, FAMIA • Deepti Pandita, MD, FACP, FAMIA

• Learn how augmented intelligence (AI) and machine learning (ML) technologies are used in health care to tackle administrative tasks and other burdensome aspects of clinical care.
• Identify the risks and benefits of these technologies and what questions to ask when you or your practice are considering integrating them.

Moderator: Ankita Sagar, MD, MPH, FACP
Panelist: Elizabeth Cerceo, MD, FACP, FHM

• Describe the internal medicine physician shortage and features of thriving systems where physicians, their teams, and patients' needs are met long term.
• List strategies and interventions proven to help retain internal medicine physicians in the clinical workforce.
• Identify strategies to promote the fulfillment of practicing internal medicine physicians and their clinical teams.

Moderator: William D. Surkis, MD, FACP
Moderator: William D. Surkis, MD, FACP
Moderator: William D. Surkis, MD, FACP
Panelist: Michael Ganio, PharmD, MS, FASHP
Panelist: Michael Ganio, PharmD, MS, FASHP
Panelist: Michael Ganio, PharmD, MS, FASHP

• Describe the impact of drug shortages on patient care.
• List strategies the U.S. Food and Drug Administration and other key stakeholders are taking to mitigate drug shortages.
• Identify two to three examples of how practicing physicians can limit the negative impact of drug shortages on their patients.

Speaker: Kerry Reynolds, MD

• In which patients should immunotherapy-related toxicities be considered, and how should these patients be evaluated?
• What is the role of the multidisciplinary team in management of immune-mediated toxicities?
• What are the currently available clinical practice guidelines for identifying and managing toxicities related to immunotherapy?

Speaker: Aneesh V. Tolat, MD, FACC, FHRS

• How do I manage patients presenting with their first episode of atrial fibrillation and those with a history of atrial fibrillation presenting with rapid ventricular rates?
• What are the management options for patients with refractory atrial fibrillation?
• What are the special considerations for adjusting anticoagulants in hospitalized patients?

Speaker: Rodolfo J. Galindo, MD, FACE

• When and how does the physician screen patients for inpatient hyperglycemia?
• How does one choose the right inpatient treatment (insulin vs. oral agents) for the management of diabetes and hyperglycemia?
• How does the physician choose the right diabetes treatment after discharge?

Speaker: Avital Y. O'Glasser, MD, FACP, SFHM, DFPM

• What are the most recent perioperative guidelines, and how does one apply them in clinical practice?
• What is the role of the medical consultant in the perioperative period?
• How are troponin elevation and myocardial ischemia in the postoperative period addressed?

Speaker: Richard E. Greene, MD, MHPE, FACP

• How should the sexual history evolve from what physicians were taught in medical school?
• What are the essential questions of the sexual history in 2025?
• How will having a better sexual history impact the care of my patients?

Speaker: Scott C. Woller, MD, FACP, FCCP

• Periprocedural anticoagulation management: Balancing thrombosis and bleeding risk.
• Direct oral anticoagulant use in special populations, such as extremes of body weight, kidney, and hepatic insufficiency. Is there a role for dose-adjustment?
• When should I elect a vitamin K antagonist over a direct oral anticoagulant?

Speaker: Kristen Manley, MD, Member

• What are the common oncologic emergencies encountered in the hospital?
• What are the high-value signs and symptoms that help to identify common oncologic emergencies?
• How are common oncologic emergencies best managed?

Speaker: Farid Jadbabaie, MD

• How should physicians effectively manage patients hospitalized with heart failure with preserved ejection fraction (HFpEF)?
• Which therapies should be initiated in patients with HFpEF before discharge?
• When should a patient diagnosed with HFpEF be referred to advanced heart failure services?

Speaker: Christian J. Woods, MD, FACP, FCCP, FIDSA

• What are the current diagnostic approaches to improve appropriate antibiotic usage for respiratory infections?
• What are the updates for managing community- and hospital-acquired pneumonia?
• What are the latest recommendations for managing influenza?

Speaker: Michael E. Goldberg, DO

• What imaging should a physician order if they are concerned about gallstones?
• How does an internal medicine physician diagnose and manage pancreatic insufficiency?
• How does one monitor pancreatic cysts?

Speaker: Srilakshmi Mitta, MD

• What are the common peripartum emergencies that inpatient physicians may get called to help with?
• What are the strategies to expeditiously manage such emergencies?
• What are the best practices in co-managing these patients with the obstetric team?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Panelists: J. Thomas CrossJr., MD, MPH, FACP, FAAP
Panelists: J. Thomas CrossJr., MD, MPH, FACP, FAAP
Panelists: J. Thomas CrossJr., MD, MPH, FACP, FAAP
Panelists: J. Thomas CrossJr., MD, MPH, FACP, FAAP • Devan Kansagara, MD, MCR, FACP • Devan Kansagara, MD, MCR, FACP • Devan Kansagara, MD, MCR, FACP • Devan Kansagara, MD, MCR, FACP

• What are the latest ACP clinical guidelines and best practice advice relating to treatments for depression and the use of cannabis for management of noncancer chronic pain?
• What are the current standards of evidence-based care?
• How can I implement these clinical guidelines and best practice advice into my practice?

Moderator: Rachel P. Brook, MD, FACP
Moderator: Rachel P. Brook, MD, FACP
Moderator: Rachel P. Brook, MD, FACP
Panelists: William F. Lewis, MD
Panelists: William F. Lewis, MD
Panelists: William F. Lewis, MD • Ami Thakor Philipp, MD • Ami Thakor Philipp, MD • Ami Thakor Philipp, MD • Nirav R. Shah, MD, MPH, MACP • Nirav R. Shah, MD, MPH, MACP • Nirav R. Shah, MD, MPH, MACP

• Dermatology:
  • 1. What is the management and work-up of nonspecific hair loss? What about minoxidil in young patients?
  • 2. Dermatology best practices: Should everyone be getting an annual total body skin examination? What are the best and worst use cases of liquid nitrogen for busy primary care physicians?
• Allergy and Immunology:
  • 1. At what point should we be considering biologic agents for our patients with chronic rhinosinusitis or asthma? Are we under- or overutilizing these medications?
  • 2. For our primary care adult patients, who is a candidate for omalizumab injections for food allergies?
  • 3. When should the generalist consider intranasal epinephrine versus injectable?
• Artificial Intelligence:
  • 1. What are some high-quality artificial intelligence (AI) diagnostic reasoning tools, and how do you evaluate these AI products to assess for diagnostic accuracy? What are some common pitfalls to be aware of when using these tools?
  • 2. What are three ways you could integrate AI into your daily practice as a generalist to improve patient outcomes?

Moderator: Alexandra M. Goodwin, MD, Member
Moderator: Alexandra M. Goodwin, MD, Member
Moderator: Alexandra M. Goodwin, MD, Member
Panelists: Victoria E. Burke, MD, FACP
Panelists: Victoria E. Burke, MD, FACP
Panelists: Victoria E. Burke, MD, FACP • Jennifer Haglund, MD • Jennifer Haglund, MD • Jennifer Haglund, MD • Fred A. Lopez, MD, MACP • Fred A. Lopez, MD, MACP • Fred A. Lopez, MD, MACP • Bobby B. Najari, MD, MSc • Bobby B. Najari, MD, MSc • Bobby B. Najari, MD, MSc

• Infectious Diseases:
  • 1. What is the current evidence for outpatient treatment of COVID-19 in vaccinated versus unvaccinated patients?
  • 2. Pneumococcal soup: For patients vaccinated with PCV23 and either Prevnar 13 or Prevnar 20, is there a need for PCV21? What are the guidelines around pneumococcal vaccination?
  • 3. What is the evidence supporting doxy PEP (doxycycline postexposure prophylaxis), and what are the best practices for counseling patients on its use?
• Men's Health:
  • 1. How can primary care physicians manage low testosterone? Who should be receiving testosterone replacement, and what are the risks of hormone replacement therapy?
  • 2. How can primary care physicians manage lower urinary tract symptoms in men? What are the updates in evidence-based treatments for benign prostatic hyperplasia (BPH) and distinguishing and managing overactive bladder and BPH in men?
• Hepatology:
  • 1. What are the emerging evidence-based medications for treatment of MAFLD, including, but not limited to, GLP-1 receptor agonists ? When do you initiate medication treatment versus lifestyle modifications?
  • 2. What should we know about the initiation of treatment of hepatitis C in hospitalized patients? For what patient populations is it indicated and most beneficial?

Moderator: James O'Keefe, MD, FACP
Moderator: James O'Keefe, MD, FACP
Moderator: James O'Keefe, MD, FACP
Moderator: James O'Keefe, MD, FACP
Panelists: Walter S. Dunn, MD, PhD
Panelists: Walter S. Dunn, MD, PhD
Panelists: Walter S. Dunn, MD, PhD
Panelists: Walter S. Dunn, MD, PhD • Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC • Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC • Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC • Keith C. Ferdinand, MD, FACC, FAHA, FNLA, FASPC • Jose Ricardo Lopez Castellanos, MD • Jose Ricardo Lopez Castellanos, MD • Jose Ricardo Lopez Castellanos, MD • Jose Ricardo Lopez Castellanos, MD

• Psychiatry:
  • 1. What are the latest updates in treating treatment-resistant depression, including the role and indications for ketamine?
  • 2. What are the current indications and emerging data for the use of hallucinogens like psilocybin? For which conditions should we consider these treatments?
• Neurology:
  • 1. For patients with autonomic dysfunction, what is the evidence-based approach to initiation and selection of blood pressure–augmenting medications? When should we consider pyridostigmine, and what should internal medicine physicians know about its risk factors and management?
  • 2. For common neurodegenerative diseases encountered in primary care, how is the role of biomarker testing evolving? What are some high-yield diagnostic tests, such as blood or CSF testing, skin biopsy, and imaging techniques, and their clinical utility in making a diagnosis?
• Cardiology:
  • 1. What is the approach to integrating Lp(a) into your cardiac risk stratification? Who benefits from testing, and how do you factor the result into your management strategy?
  • 2. In patients with systolic heart failure with preserved or mildly reduced ejection fraction, when should we initiate treatment with finerenone? Should we start SGLT-2 medications in hospitalized patients? What specific patient characteristics should be considered with regard to risks and benefits?

Speaker: Deborah B. Adey, MD, FACP

• What adverse effects and complications of kidney transplant medications should I watch for?
• What potential interactions with transplant medications should I be aware of?
• What cancer screening is indicated for patients living with a kidney transplant?
• What special considerations should I be alert to for patients admitted to the hospital who are kidney transplant recipients?

Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Moderator: Amir Qaseem, MD, PhD, MHA, MRCP (Lon), FACP
Panelists: Carolyn J. Crandall, MD, MS, MACP
Panelists: Carolyn J. Crandall, MD, MS, MACP • Jeffrey A. Tice, MD, Member • Jeffrey A. Tice, MD, Member

• What are the latest ACP clinical guidelines for prevention and treatment of acute migraine?
• What are the current standards of evidence-based care?
• How can I implement these guidelines into my practice?

Speaker: Kara Aplin, MD, FACP

• What is the best approach to treating opioid use disorder (OUD) in the inpatient setting?
• What inpatient pharmacologic interventions can be initiated for the treatment of OUD?
• What are the high-value care approaches in care transitions on discharge and to avoid readmissions?

Speaker: Sonia Malhotra, MD, MS, Member, FAAP, FAAHPM

• When is it appropriate to consider goal-concordant palliative care in the inpatient setting for nonmalignant, progressive, and chronic conditions?
• What are the best practices in conducting successful family meetings pertaining to palliative care?
• What is the approach to managing non–pain-related symptoms of patients receiving palliative care?
• How do internal medicine physicians provide palliative care in the absence of available palliative care consult service in the inpatient setting?

Director: Geno J. Merli, MD, MACP, FHM, FSVM
Co-Director: Howard Weitz, MD, MACP, FRCP (Lond.), FACC
Panelists: Margaret M. Beliveau, MD, FACP • James W. Heitz, MD, FACP, FASA • Gregary D. Marhefka, MD, FACP, FACC • Karen F. Mauck, MD, MSc, FACP

Speaker: Foluso A. Fakorede, MD

• Which patients should be screened for peripheral vascular disease?
• How should patients with PAD be managed with respect to their cardiovascular risk?
• What conservative treatment options are available, and when should they be instituted?
• When should invasive management strategies be considered?

Speaker: Fred R. BuckholdIII, MD, FACP

• What are the important hospital quality metrics relevant to the hospitalist?
• What are practical tips for an early career hospitalist to incorporate quality improvement (QI) in their daily workflow?
• How does one grow a QI-minded hospital medicine group?

Speaker: Brian Morrissey, MD

• What is the epidemiology and unmet needs in patients with bronchiectasis?
• What is the evidence of long-term inhaled or oral antibiotics in clinical practice for patients with bronchiectasis?
• What are the evidence-based interventions for mucous clearance, including airway clearance/physiotherapy and mucous-targeting treatments?
• What are the future proposed targets of therapy for patients with bronchiectasis?

Speaker: Marjorie Golden, MD, FACP

• What are the common skin and soft tissue infections leading to hospital admission or that evolve during a hospital stay?
• How does one accurately diagnose cellulitis, and what are its mimics?
• When should internal medicine physicians seek specialist consultation from infectious diseases, surgery, or others?

Speaker: Carolyn M. D'Ambrosio, MS, MD

• Are there any new treatment modalities for insomnia?
• I suspect my patient has a sleep disorder, but they do not want to sleep in a lab. Any other options?
• My patient with severe obstructive sleep apnea (OSA) cannot tolerate CPAP. What can I offer?
• Are there any new technology devices or artificial intelligence for sleep health?

Speaker: Win K. Shen, MD

• What are the common causes of syncope requiring hospital admission?
• How should syncope be evaluated in the inpatient setting?
• When should you advance the care beyond a short stay for syncope?
• What is the best evaluation and management of patients with recurrent orthostatic hypotension?

Speaker: Rafael H. Llinas, MD

• What are the current guidelines in the management of stroke and TIA?
• Which patients with TIA can be safely monitored as outpatients after an ED visit?
• What are the high-cost emerging therapies in the management of stroke and TIA, and for whom are they indicated?

Speaker: Matthew Ettleson, MD

• When and how should physicians screen patients for thyroid disorders?
• When and how should a patient with subclinical hypo- and hyperthyroidism be treated?
• How does the physician counsel patients on the benefits and risks of treating subclinical thyroid disorders?

Speaker: Elizabeth Cerceo, MD, FACP, FHM

• How can my ICU help lessen climate change?
• How can I help prepare my ICU for the worsening impacts of climate change?
• What is the COP26 Health Programme? Any updates from COP28?

Speaker: Michael J. Sanley, MD

• What are the common conditions associated with wheezing in inpatients?
• What are the various causes of wheezing at the bedside, from upper airway to lower airway and from airway inflammation to airway fluid?
• Is there a role for spirometry and additional pulmonary function testing in the plan of care for such hospitalized patients, and what is the timing of such testing if indicated?

Presenter: Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Irl B. Hirsch, MD, MACP

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: John G. McCarthy, MD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Thomas E. Finucane, MD, MACP
Co-Presenter: Stephanie Nothelle, MD

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: I. Romina Sosa, MD, PhD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Brian Markoff, MD, FACP, SFHM

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Erica N. Johnson, MD, FACP, FIDSA

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Belinda Jim, MD

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Marc Shapiro, MD, Member

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Stephanie Christenson, MD, MAS

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Robert M. McLean, MD, MACP

• Presentation of 6-12 papers published during the past 12-15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Speaker: Stephanie Christenson, MD, MAS

• What are the various intravenous (IV) fluid formulations and their indications that physicians should know?
• How does the physician assess volume status of the patient, and what should be considered when prescribing the type, dose, and duration of IV fluids?
• What are the adverse events associated with various IV fluid formulations that physicians should be aware of?
• What conditions can mimic fluid overload?